Albumin-bilirubin grade as a significant prognostic factor in patients with non-small cell lung cancer treated with anti-PD-1-based therapy: A multicenter retrospective study.

Shinkichi Takamori,Kazuki Takada,Mototsugu Shimokawa,Gouji Toyokawa,Shinichiro Shimamatsu,Fumihiko Hirai,Tetsuzo Tagawa,Tatsuro Okamoto,Motoharu Hamatake,Yuko Tsuchiya-Kawano,Kohei Otsubo,Koji Inoue,Yasuto Yoneshima,Kentaro Tanaka,Isamu Okamoto,Yoichi Nakanishi,Masaki Mori

Albumin-bilirubin grade as a significant prognostic factor in patients with non-small cell lung cancer treated with anti-PD-1-based therapy: A multicenter retrospective study.

2021

Shinkichi Takamori
Kazuki Takada
Mototsugu Shimokawa
Gouji Toyokawa
Shinichiro Shimamatsu
Fumihiko Hirai
Tetsuzo Tagawa
Tatsuro Okamoto
Motoharu Hamatake
Yuko Tsuchiya-Kawano
Kohei Otsubo
Koji Inoue
Yasuto Yoneshima
Kentaro Tanaka
Isamu Okamoto
Yoichi Nakanishi
Masaki Mori

e21125Background: Albumin-bilirubin (ALBI) grade is calculated from albumin and bilirubin values as continuous variables, allowing an accurate evaluation of liver function. Some studies showed that...

Keywords:

in patient
Gastroenterology
Lung cancer
Bilirubin
Retrospective cohort study
non small cell
Internal medicine
Medicine
Albumin
anti pd 1
liver function

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations